Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |